Merck (MRK) Misses Q4 EPS by 6c, FY Guidance Tops Views
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $76.31 +1.09%
Revenue Growth %: +5.7%
Financial Fact:
Net Income Attributable to Merck & Co., Inc.: 7.95B
Today's EPS Names:
JFIN, JKS, More
Revenue Growth %: +5.7%
Financial Fact:
Net Income Attributable to Merck & Co., Inc.: 7.95B
Today's EPS Names:
JFIN, JKS, More
Trade Now!
Join SI Premium – FREE
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Merck (NYSE: MRK) reported Q4 EPS of $1.32, $0.06 worse than the analyst estimate of $1.38. Revenue for the quarter came in at $12.5 billion versus the consensus estimate of $12.68 billion.
GUIDANCE:
Merck sees FY2021 EPS of $6.48-$6.68, versus the consensus of $6.41. Merck sees FY2021 revenue of $51.8-53.8 billion, versus the consensus of $51.77 billion.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JinkoSolar (JKS) Misses Q4 EPS by 25c, Revenue Beats, Offers Guidance
- Alphatec Holdings (ATEC) Announces Preliminary Q1 Revenue Results and Provides Corporate Updates
- Merck's (MRK) KEYTRUDA Demonstrated Superior Disease-Free Survival Compared With Placebo as Adjuvant Therapy in Patients With RCC Following Surgery
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
